Abstract
Background
Worsening heart failure (WHF) is defined as persistent or worsening symptoms of heart failure that require an escalation in intravenous therapy or initiation of mechanical and ventilatory support during hospitalization. We assessed a simplified version of WHF called diuretic failure (DF), defined as an escalation of loop diuretic dosing after 48 h, and assessed its effects on mortality and rehospitalizations at 60-days.
Methods
We conducted a multicenter retrospective study between December 1, 2017 and January 1, 2020. We identified 1389 patients of which 6.4% experienced DF.
Results
There was a significant relationship between DF and cumulative rates of 60-day mortality and 60-day rehospitalizations (p = 0.0002 and p = 0.0214). After multivariate adjustment, DF was associated with longer hospital stay (p < 0.0001), increased rate of 60-day mortality (p = 0.026), 60-day rehospitalizations (p = 0.036), and a composite outcome of 60-day mortality and 60-day cardiac rehospitalizations (p = 0.018).
Conclusions
DF has a strong relationship with adverse heart failure outcomes suggesting it is a simple yet robust prognostic indicator which can be used in real time to identify high-risk patients during hospitalization and beyond.
Similar content being viewed by others
References
Akintoye E, Briasoulis A, Egbe A, Dunlay SM, Kushwaha S, Levine D, Afonso L, Mozaffarian D, Weinberger J (2017) National trends in admission and in-hospital mortality of patients with heart failure in the united states (2001–2014). J Am Heart Assoc 6(12):e006955
Tang WHW, Grodin JL (2015) Worsening heart failure: challenges as a therapeutic target. JACC Heart Fail 3:404–407
Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie BM, Ponikowski P, Bloomfield DM, O’Connor CM (2010) Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure–association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology 115:29–36
Mentz RJ, Metra M, Cotter G, Milo O, McKendry C, Chiswell K, Davison BA, Cleland JG, Bloomfield DM, Dittrich HC, Fiuzat M, Ponikowski P, Givertz MM, Voors AA, Teerlink JR, O’Connor CM (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. Eur J Heart Fail 17:697–706
Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T (2013) REVIVE heart failure study group. effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 1:103–111
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM (2013) NHLBI heart failure clinical research network low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the rose acute heart failure randomized trial. JAMA 310:2533–43
Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, Investigators PROTECT, Committees, (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419–1428
McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I, Investigators VERITAS (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298:2009–2019
Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M (2013) RELAXin in acute heart failure (RELAX-AHF) investigators serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29–39
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) NHLBI heart failure clinical research network diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805
Weatherley BD, Milo-Cotter O, Felker GM, Uriel N, Kaluski E, Vered Z, O’Connor CM, Adams KF, Cotter G (2009) Early worsening heart failure in patients admitted with acute heart failure–a new outcome measure associated with long-term prognosis? Fundam Clin Pharmacol 23:633–639
Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G (2009) Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome. J Card Fail 15:639–644
Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O’Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR, Investigators VERITAS (2014) Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail 16:1362–1371
Čerlinskaitė K, Javanainen T, Cinotti R, Mebazaa A (2018) Global research on acute conditions team (GREAT) network acute heart failure management. Korean Circ J 48:463–480
Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293
Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7:261–270
Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, Kirkpatrick JN (2010) Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105:511–516
Tabucanon T, Tang WHW (2020) Right heart failure and cardiorenal syndrome. Cardiol Clin 38:185–202
Teerlink JR, Alburikan K, Metra M, Rodgers JE (2015) Acute decompensated heart failure update. Curr Cardiol Rev 11:53–62
Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E (1993) Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 22(4):968–974
Funding
This research received no grant or financial support from any funding agency.
Author information
Authors and Affiliations
Contributions
Conceptualization: SM, MPF, M S, AS, JM, AR, MNV; Methodology: SM, MPF, MS, AS; Formal analysis and investigation: MPF, MS, AS; Writing-original draft preparation: SM; Writing-review and editing: SM, MPF, MS, ASh, JM, AR, MNV; Resources: MNV; Supervision: MNV.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of WellSpan York Hospital who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of WellSpan York Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mumtaz, S., Sharma, M., Fu, M.P. et al. Prognostic role of diuretic failure in determining mortality for patients hospitalized with acute decompensated heart failure. Heart Vessels 37, 1373–1379 (2022). https://doi.org/10.1007/s00380-022-02042-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-022-02042-x